Literature DB >> 1967226

Antagonism of benzodiazepine-fentanyl anaesthesia with flumazenil.

S Kaukinen1, J Kataja, L Kaukinen.   

Abstract

The specific benzodiazepine antagonist flumazenil (Ro 15-1788) (Ro) was given in a double-blind study to 40 adult orthopaedic patients in order to determine if it shortens the immediate recovery time after benzodiazepine-fentanyl anaesthesia. On the evening before operation the patients were premedicated orally with 1-2 mg of flunitrazepam and 30 min before the induction of anaesthesia with 7.5 mg midazolam. Induction of anaesthesia was carried out with flunitrazepam 0.03-0.04 mg.kg-1 and fentanyl 0.1 mg IV. Anaesthesia was maintained with fentanyl (5.9 microgram.kg-1.h-1) and nitrous oxide. After the reversal of muscle relaxation, 20 patients received a placebo and 20 patients Ro, as boluses up to 10 ml, until the effect of awakening was noticed. The dose of Ro (0.1 mg.ml-1) required was 6.8 +/- 2.9 micrograms.kg-1 and that of placebo 10 +/- 0 ml. Patients given Ro woke up faster than patients given placebo. Ro patients were more alert than patients given placebo until 120 min after the injection or the test drug. After this patients in both groups behaved similarly. Eight patients given Ro and one given placebo showed some mild adverse reaction for 5-60 min after the administration of Ro or placebo (e.g., nausea, shivering). This study indicates that flumazenil speeds up awakening after benzodiazepine-fentanyl anaesthesia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1967226     DOI: 10.1007/BF03007482

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  20 in total

1.  Clinical evaluation of a specific benzodiazepine antagonist (RO 15-1788). Studies in elderly patients after regional anaesthesia under benzodiazepine sedation.

Authors:  B Ricou; A Forster; A Brückner; P Chastonay; M Gemperle
Journal:  Br J Anaesth       Date:  1986-09       Impact factor: 9.166

2.  Randomized clinical investigation of Ro 15-1788, a benzodiazepine antagonist, in reversing the central effects of flunitrazepam.

Authors:  S Jensen; L Kirkegaard; B N Anderson
Journal:  Eur J Anaesthesiol       Date:  1987-03       Impact factor: 4.330

3.  The effects of a benzodiazepine antagonist Ro 15-1788 in the presence of stable concentrations of midazolam.

Authors:  P M Lauven; H Schwilden; H Stoeckel; D J Greenblatt
Journal:  Anesthesiology       Date:  1985-07       Impact factor: 7.892

4.  Pharmacokinetics of the selective benzodiazepine antagonist Ro 15-1788 in man.

Authors:  U Klotz; G Ziegler; I W Reimann
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Intraoperative awareness during high-dose fentanyl--oxygen anesthesia.

Authors:  J C Hilgenberg
Journal:  Anesthesiology       Date:  1981-04       Impact factor: 7.892

6.  [Ro 15-1788 antagonizes reliably the Benzodiazepine effect after Flunitrazepam combination anesthesias].

Authors:  W Tolksdorf; A Pirwitz; C Bentzinger; J Pfeiffer
Journal:  Anaesthesist       Date:  1987-05       Impact factor: 1.041

7.  Anesthetic induction with fentanyl.

Authors:  P L Bailey; J Wilbrink; P Zwanikken; N L Pace; T H Stanley
Journal:  Anesth Analg       Date:  1985-01       Impact factor: 5.108

8.  Benzodiazepine antagonist Ro 15-1788. Antagonism of diazepam sedation in outpatients undergoing gastroscopy.

Authors:  L Kirkegaard; L Knudsen; S Jensen; A Kruse
Journal:  Anaesthesia       Date:  1986-12       Impact factor: 6.955

9.  Determination of Ro 15-1788, a benzodiazepine antagonist, in human plasma by gas-liquid chromatography with nitrogen-phosphorus detection. Application to single-dose pharmacokinetic studies.

Authors:  D R Abernethy; R M Arendt; P M Lauven; D J Greenblatt
Journal:  Pharmacology       Date:  1983       Impact factor: 2.547

10.  Selective antagonists of benzodiazepines.

Authors:  W Hunkeler; H Möhler; L Pieri; P Polc; E P Bonetti; R Cumin; R Schaffner; W Haefely
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

View more
  1 in total

Review 1.  Flumazenil. A reappraisal of its pharmacological properties and therapeutic efficacy as a benzodiazepine antagonist.

Authors:  R N Brogden; K L Goa
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.